IFNG and neoplasm: LC-MS approaches have also revealed that the nature of the tumour ligandome can be influenced by immune activity in the tumour microenvironment—Wickstrom et al. found that ligandome-validated peptides from resected tumour were only expressed on patient-matched tumour cell lines in vitro after treatment with IFN-g [104].